OTC Artificial Tears Market Size, Share, Trends, Growth and Forecast Report 2021-2027

Description

The global OTC Artificial Tears market garnered revenue around USD 6,582 million in 2020 and projected to reach USD 8,599.50 million in 2027, with at a compound annual growth rate (CAGR) 5.96% throughout the estimate period from 2021 to 2027. Artificial tears also known as ocular lubricants are lubricating eye drops, which are formulated to provide relief from irritation, burning, discomfort, and dryness of the ocular surface. It maintains moisture at the outer surface of the eyes. Over-the-counter (OTC) artificial tears are the eye drops which are available without prescription. 

The growth of the global OTC artificial tears market is majorly driven by increase in geriatric population; rise in prevalence of eye diseases such as dry eye syndrome and allergic conjunctivitis; surge in demand for artificial tears products; and increase in investment in R&D activities by various healthcare companies. In addition, increase in number of eye surgeries, rise in awareness about management of dry eye syndrome, and initiatives taken by the government for the development & production of different novel OTC artificial tears propel the growth of the market. However, side effects associated with the OTC artificial tears such as blurred vision, redness around the eye, and skin rashes, are expected to restrict the OTC artificial tears market growth during the forecast period.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the OTC Artificial Tears market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the OTC Artificial Tears market growth.

The global OTC Artificial Tears market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

The key players operating in the global market include AbbVie, Inc., Akorn, Inc., Alcon, Bausch & Lomb, Johnson & Johnson, Ocusoft, Santen Pharmaceutical Co. Ltd., Similasan Corporation, Sun Pharmaceutical Industries Limited and Ursapharm Arzneimittel GmbH.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

By Product

·         Solution

·         Ointment

·         Emulsion

·         Gel

·         Spray Solution

·         Suspensions

By Container Type

·         Plastic Single Dose Container

·         Plastic multi-dose containers

o    Preservative-Free System

o    Preserved System

·         Spray

o    Preservative-Free System

o    Preserved System

By Formulation

·         Preservative Based

·         Non-Preservative Based

By Application

·         Dry Eye Syndrome

·         Allergies

·         Infections

·         UV & Blue Light Protection

·         Contact Lens Moisture Retention

·         Others

By Distribution Channel

·         Hospital Pharmacies

·         Drug Store & Retail Pharmacies

·         Online Pharmacies

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope: 

 

North America

United States

Canada

 

Europe

Germany

United Kingdom

Italy

France

Rest of EU

 

Asia Pacific

China

India

Japan

Southeast Asia

Rest of APAC

 

Central & South America 

Brazil 

Argentina

Rest of Central & South America 

 

Middle East and Africa

GCC

North Africa

South Africa

TABLE OF CONTENT

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global OTC Artificial Tears Market, By Product

7.1.  OTC Artificial Tears Market, by Product, 2020-2027

7.1.1.    Solution

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Ointment

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    Emulsion

7.1.3.1.        Market Revenue and Forecast (2016-2027)

7.1.4.    Gel

7.1.4.1.        Market Revenue and Forecast (2016-2027)

7.1.5.    Spray Solution

7.1.5.1.        Market Revenue and Forecast (2016-2027)

7.1.6.    Suspensions

7.1.6.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global OTC Artificial Tears Market, By Container Type

8.1.  OTC Artificial Tears Market, by Container Type, 2020-2027

8.1.1.    Plastic Single Dose Container

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Plastic multi-dose containers

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Preservative-Free System

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Preserved System

8.1.4.1.        Market Revenue and Forecast (2016-2027)

8.1.5.    Spray

8.1.5.1.        Market Revenue and Forecast (2016-2027)

8.1.6.    Preservative-Free System

8.1.6.1.        Market Revenue and Forecast (2016-2027)

8.1.7.    Preserved System

8.1.7.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global OTC Artificial Tears Market, By Formulation

9.1.  OTC Artificial Tears Market, by Formulation, 2020-2027

9.1.1.    Preservative Based

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Non-Preservative Based

9.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global OTC Artificial Tears Market, By Application

10.1.        OTC Artificial Tears Market, by Application, 2020-2027

10.1.1.  Dry Eye Syndrome

10.1.1.1.      Market Revenue and Forecast (2016-2027)

10.1.2.  Allergies

10.1.2.1.      Market Revenue and Forecast (2016-2027)

10.1.3.  Infections

10.1.3.1.      Market Revenue and Forecast (2016-2027)

10.1.4.  UV & Blue Light Protection

10.1.4.1.      Market Revenue and Forecast (2016-2027)

10.1.5.  Contact Lens Moisture Retention

10.1.5.1.      Market Revenue and Forecast (2016-2027)

10.1.6.  Others

10.1.6.1.      Market Revenue and Forecast (2016-2027)

Chapter 11.      Global OTC Artificial Tears Market, By Distribution Channel

11.1.        OTC Artificial Tears Market, by Distribution Channel, 2020-2027

11.1.1.  Hospital Pharmacies

11.1.1.1.      Market Revenue and Forecast (2016-2027)

11.1.2.  Drug Store & Retail Pharmacies

11.1.2.1.      Market Revenue and Forecast (2016-2027)

11.1.3.  Online Pharmacies

11.1.3.1.      Market Revenue and Forecast (2016-2027)

Chapter 12.      Global OTC Artificial Tears Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Product (2016-2027)

12.1.2.  Market Revenue and Forecast, by Container Type (2016-2027)

12.1.3.  Market Revenue and Forecast, by Formulation (2016-2027)

12.1.4.  Market Revenue and Forecast, by Application (2016-2027)

12.1.5.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Product (2016-2027)

12.1.6.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.1.6.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.1.6.4.      Market Revenue and Forecast, by Application (2016-2027)

12.1.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Product (2016-2027)

12.1.7.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.1.7.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.1.7.4.      Market Revenue and Forecast, by Application (2016-2027)

12.1.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Product (2016-2027)

12.2.2.  Market Revenue and Forecast, by Container Type (2016-2027)

12.2.3.  Market Revenue and Forecast, by Formulation (2016-2027)

12.2.4.  Market Revenue and Forecast, by Application (2016-2027)

12.2.5.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Product (2016-2027)

12.2.6.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.2.6.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.2.6.4.      Market Revenue and Forecast, by Application (2016-2027)

12.2.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Product (2016-2027)

12.2.7.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.2.7.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.2.7.4.      Market Revenue and Forecast, by Application (2016-2027)

12.2.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Product (2016-2027)

12.2.8.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.2.8.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.2.8.4.      Market Revenue and Forecast, by Application (2016-2027)

12.2.8.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Product (2016-2027)

12.2.9.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.2.9.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.2.9.4.      Market Revenue and Forecast, by Application (2016-2027)

12.2.9.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Product (2016-2027)

12.3.2.  Market Revenue and Forecast, by Container Type (2016-2027)

12.3.3.  Market Revenue and Forecast, by Formulation (2016-2027)

12.3.4.  Market Revenue and Forecast, by Application (2016-2027)

12.3.5.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Product (2016-2027)

12.3.6.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.3.6.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.3.6.4.      Market Revenue and Forecast, by Application (2016-2027)

12.3.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Product (2016-2027)

12.3.7.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.3.7.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.3.7.4.      Market Revenue and Forecast, by Application (2016-2027)

12.3.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Product (2016-2027)

12.3.8.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.3.8.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.3.8.4.      Market Revenue and Forecast, by Application (2016-2027)

12.3.8.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Product (2016-2027)

12.3.9.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.3.9.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.3.9.4.      Market Revenue and Forecast, by Application (2016-2027)

12.3.9.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Product (2016-2027)

12.4.2.  Market Revenue and Forecast, by Container Type (2016-2027)

12.4.3.  Market Revenue and Forecast, by Formulation (2016-2027)

12.4.4.  Market Revenue and Forecast, by Application (2016-2027)

12.4.5.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Product (2016-2027)

12.4.6.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.4.6.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.4.6.4.      Market Revenue and Forecast, by Application (2016-2027)

12.4.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Product (2016-2027)

12.4.7.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.4.7.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.4.7.4.      Market Revenue and Forecast, by Application (2016-2027)

12.4.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Product (2016-2027)

12.4.8.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.4.8.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.4.8.4.      Market Revenue and Forecast, by Application (2016-2027)

12.4.8.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Product (2016-2027)

12.4.9.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.4.9.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.4.9.4.      Market Revenue and Forecast, by Application (2016-2027)

12.4.9.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Product (2016-2027)

12.5.2.  Market Revenue and Forecast, by Container Type (2016-2027)

12.5.3.  Market Revenue and Forecast, by Formulation (2016-2027)

12.5.4.  Market Revenue and Forecast, by Application (2016-2027)

12.5.5.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Product (2016-2027)

12.5.6.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.5.6.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.5.6.4.      Market Revenue and Forecast, by Application (2016-2027)

12.5.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Product (2016-2027)

12.5.7.2.      Market Revenue and Forecast, by Container Type (2016-2027)

12.5.7.3.      Market Revenue and Forecast, by Formulation (2016-2027)

12.5.7.4.      Market Revenue and Forecast, by Application (2016-2027)

12.5.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2027)

Chapter 13.  Company Profiles

13.1.              AbbVie, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Akorn, Inc.

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Alcon

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Bausch & Lomb

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Johnson & Johnson

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Ocusoft

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Santen Pharmaceutical Co. Ltd.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Similasan Corporation

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Sun Pharmaceutical Industries Limited

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Ursapharm Arzneimittel GmbH.

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

15.2.              Glossary of Terms

Choose License Type

Checkout Inquiry Sample